Additional Benefit of Chinese Medicine Formulae Including for Diabetes Mellitus: Current State of Evidence

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2020 Nov 27

PMID 33244311

Citations 4

Authors

Lu Sun

Yuan Ming Di

Chuanjian Lu

Xinfeng Guo

Xianyu Tang

Anthony Lin Zhang

Charlie Changli Xue

Guanjie Fan

Affiliations

Soon will be listed here.

Abstract

Background: Chinese medicine has been used to treat diabetes symptoms for thousands of years. or is a Chinese medicinal herb that is routinely used in the treatment of diabetes mellitus (DM).

Objective: The purpose of this study is to evaluate the evidence of the added benefits and safety of herbal formulae containing in clinical studies and the possible mechanisms of in the prevention and treatment of DM in experimental studies.

Methods: We searched nine databases for randomized controlled trials (RCTs) that included in the formulae in the treatment of type 2 DM. Furthermore, experimental studies on the prevention and treatment of DM by in English- and Chinese-language databases were identified.

Results: Fifty-three moderate quality RCTs with herbal formulae containing were identified. Results from meta-analysis indicated that alone or formulae containing in addition to conventional treatments could benefit people with type 2 DM in lowering blood glucose, blood lipids and reducing insulin resistance. Moreover, adverse events were significantly lower in the CHM plus conventional group than those in the conventional group. may exert the benefit through various mechanisms including inhibition of -glucosidase and DPP-IV activity, increase of endogenous GLP-1 and immune regulating activities.

Conclusion: Evidence from this review suggested that there appeared to be added clinical benefits associated with the use of for DM, whether as a food supplement or as a CHM combined with hypoglycemic agents with a good safety profile.

Citing Articles

Biochanin A abrogates osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS/MAPK signaling pathway based on integrating molecular docking and experimental validation.

He Q, Yang J, Chen W, Pan Z, Chen B, Zeng J BMC Complement Med Ther. 2024; 24(1):24.

PMID: 38191438 PMC: 10773052. DOI: 10.1186/s12906-023-04332-x.

Integrative Approach to Identifying System-Level Mechanisms of Chung-Sang-Bo-Ha-Hwan's Influence on Respiratory Tract Diseases: A Network Pharmacological Analysis with Experimental Validation.

Park S, Kim K, Lee W, Kim C, Lee S Plants (Basel). 2023; 12(17).

PMID: 37687271 PMC: 10489874. DOI: 10.3390/plants12173024.

A network pharmacology and molecular docking investigation on the mechanisms of Shanyaotianhua decoction (STT) as a therapy for psoriasis.

Yue C, Feng J, Gao A Medicine (Baltimore). 2023; 102(34):e34859.

PMID: 37653756 PMC: 10470816. DOI: 10.1097/MD.0000000000034859.

The Synergistic Effect of Zuogui Pill and Eldecalcitol on Improving Bone Mass and Osteogenesis in Type 2 Diabetic Osteoporosis.

Shi T, Liu T, Kou Y, Rong X, Meng L, Cui Y Medicina (Kaunas). 2023; 59(8).

PMID: 37629706 PMC: 10456904. DOI: 10.3390/medicina59081414.

References

Hsu J, Wu Y, Liu I, Cheng J . Dioscorea as the principal herb of Die-Huang-Wan, a widely used herbal mixture in China, for improvement of insulin resistance in fructose-rich chow-fed rats. J Ethnopharmacol. 2007; 112(3):577-84. DOI: 10.1016/j.jep.2007.05.013. View

. 2. Classification and Diagnosis of Diabetes: . Diabetes Care. 2019; 43(Suppl 1):S14-S31. DOI: 10.2337/dc20-S002. View

Li Q, Li W, Gao Q, Zou Y . Hypoglycemic Effect of Chinese Yam (Dioscorea opposita rhizoma) Polysaccharide in Different Structure and Molecular Weight. J Food Sci. 2017; 82(10):2487-2494. DOI: 10.1111/1750-3841.13919. View

Fu Y, Chen S, Huang P, Li Y . Application of bubble separation for quantitative analysis of choline in Dioscorea (yam) tubers. J Agric Food Chem. 2005; 53(7):2392-8. DOI: 10.1021/jf048501h. View

Kim S, Shin S, Hyun B, Kong H, Han S, Lee A . Immunomodulatory Effects of Dioscoreae Rhizome Against Inflammation through Suppressed Production of Cytokines Via Inhibition of the NF-κB Pathway. Immune Netw. 2012; 12(5):181-8. PMC: 3509162. DOI: 10.4110/in.2012.12.5.181. View

Fan Y, He Q, Luo A, Wang M, Luo A . Characterization and antihyperglycemic activity of a polysaccharide from Dioscorea opposita Thunb roots. Int J Mol Sci. 2015; 16(3):6391-401. PMC: 4394538. DOI: 10.3390/ijms16036391. View

Zhang X, Liu Y, Xiong D, Xie C . Insulin combined with Chinese medicine improves glycemic outcome through multiple pathways in patients with type 2 diabetes mellitus. J Diabetes Investig. 2015; 6(6):708-15. PMC: 4627549. DOI: 10.1111/jdi.12352. View

Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q . Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA. 2017; 317(24):2515-2523. PMC: 5815077. DOI: 10.1001/jama.2017.7596. View

Jeon J, Lee J, Lee C, Kim J, Kim S, Nam D . Effect of ethanol extract of dried Chinese yam (Dioscorea batatas) flour containing dioscin on gastrointestinal function in rat model. Arch Pharm Res. 2006; 29(5):348-53. DOI: 10.1007/BF02968583. View

10.

Gagnier J, Boon H, Rochon P, Moher D, Barnes J, Bombardier C . Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med. 2006; 144(5):364-7. DOI: 10.7326/0003-4819-144-5-200603070-00013. View

11.

Pan X, Li G, Hu Y, Wang J, Yang W, An Z . Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997; 20(4):537-44. DOI: 10.2337/diacare.20.4.537. View

12.

Schulz K, Altman D, Moher D . CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother. 2011; 1(2):100-7. PMC: 3043330. DOI: 10.4103/0976-500X.72352. View

13.

Yang M, Chin Y, Yoon K, Kim J . Phenolic compounds with pancreatic lipase inhibitory activity from Korean yam (Dioscorea opposita). J Enzyme Inhib Med Chem. 2013; 29(1):1-6. DOI: 10.3109/14756366.2012.742517. View

14.

Yang W, Wang Y, Li X, Yu P . Purification and structural characterization of Chinese yam polysaccharide and its activities. Carbohydr Polym. 2014; 117:1021-1027. DOI: 10.1016/j.carbpol.2014.09.082. View

15.

Bakare-Odunola M, Mustapha A, Abdu Aguye I . Effect of Nigerian meals on the pharmacokinetics of chlorpropamide in type II diabetic patients. Eur J Drug Metab Pharmacokinet. 2008; 33(1):31-5. DOI: 10.1007/BF03191016. View

16.

Wolever T . The glycemic index. World Rev Nutr Diet. 1990; 62:120-85. View

17.

Zhang S, Wu D, Li H, Zhu J, Hu W, Lu M . Rapid identification of α-glucosidase inhibitors from Dioscorea opposita Thunb peel extract by enzyme functionalized FeO magnetic nanoparticles coupled with HPLC-MS/MS. Food Funct. 2017; 8(9):3219-3227. DOI: 10.1039/c7fo00928c. View

18.

Sagara K, Ojima M, Suto K, Yoshida T . Quantitative determination of allantoin in Dioscorea rhizome and an Oriental pharmaceutical preparation, hachimi-gan, by high-performance liquid chromatography. Planta Med. 1989; 55(1):93. DOI: 10.1055/s-2006-961841. View

19.

van de Laar F, Lucassen P, Akkermans R, van de Lisdonk E, Rutten G, van Weel C . Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. Diabetes Care. 2004; 28(1):154-63. DOI: 10.2337/diacare.28.1.154. View

20.

Niu C, Chen W, Wu H, Cheng K, Wen Y, Lin K . Decrease of plasma glucose by allantoin, an active principle of yam ( Dioscorea spp.), in streptozotocin-induced diabetic rats. J Agric Food Chem. 2010; 58(22):12031-5. DOI: 10.1021/jf103234d. View